Though the focus of our review was to determine the association between breast cancer prognosis and carriership of the BRCA1 and BRCA2 mutations separately, there were many studies combining both groups in their analyses (S7 Supporting Information). This evidence concerns the gene BRCA2 and breast carcinoma.